PLXNB2 and prostate carcinoma: Inhibiting PLXNB2 suppresses the development of xenograft tumors in mice (Yu et al., 2017)Inhibiting PLXNB2 makes prostate cancer stem cells more sensitive to chemotherapy (Li et al., 2020)Motor sensory recovery following spinal cord injury is impaired in mice lacking Plxnb2 in myeloid cells (X. Zhou et al., 2020)